BSG and ovarian carcinoma: Although Ishibashi et al (2004) reported that EMMPRIN expression was not associated with the recurrence-free survival of oesophageal squamous cell carcinoma, Davidson et al (2003) found that EMMPRIN was a good prognostic marker in ovarian carcinoma.